FibroNest

The First Single-Fiber, High-Resolution

and Fully Translational Quantitative AI Digital Pathology image analysis Method for the Phenotypic Quantification of Fibrosis and it’s Associated Features

~ 9 Phase 2 Studies

~ 2 Phase 3 Studies

~ 15 Fibrotic Conditions

~ +22 Validated Rodent Models

~ 140 Pre-clinical Studies

~ 2 Organoid Models

~ 6.3 K Clinical Images

~ 11K Images

~ 78T Single Fibers Data

~ 9 Phase 2 Studies ~ 2 Phase 3 Studies ~ 15 Fibrotic Conditions ~ +22 Validated Rodent Models ~ 140 Pre-clinical Studies ~ 2 Organoid Models ~ 6.3 K Clinical Images ~ 11K Images ~ 78T Single Fibers Data

USINg FIBRONEST, PHARMANEST provideS HIGH RESOLUTION, SINGLE FIBER FIBROSIS PHENOTYPIC QUANTIFICATION services FROM DIGITAL IMAGES OF STAINED SLIDES FOR clinical and pre-clinical pharmaceutical DRUG development PROJECTS

FibroNest is a Research Only Use product for now and can be used for pre-clinical projects, for research clinical projects or as an exploratory outcome

Click here to request a Consultation

MULTIVENDOR COMPATIBILITY

FibroNest is compatible with all kinds of Digital Images, ranging from FDA-Approved WSI scanners to Fluorescence and Second Harmonic Generation microscopes

Zeiss+SHG.jpg
PRS.JPG

SINGLE-FIBER

FROM ALL KINDS OF COLLAGEN STAINED IMAGES

Collagen-stained digital images (PSR, MTC, IHC) are quantified by FibroNest at the fiber level, with full spatial localization

TRANSLATIONAL

FibroNest’s engine is fully translational from discovery to clinical development, and is validated for multiple fibrosis conditions, including liver, lung, kidney, skin ….

(see Applications pipeline here)


Phenotyping with FibroNest generates robust and continuous scores to quantify the severity and progression of fibrosis in multiple Fibrotic conditions.

FibroNest Applications Pipeline , April 2023

Click here to suggest a quality improvement or report an issue.